Aritzia Inc "UBS Evidence Lab inside: 1Q Preview: We See Limited Volatility..."

Research evidence excerpt

Aritzia Inc "UBS Evidence Lab inside: 1Q Preview: We See Limited Volatility..."

Powered by Lab Global25 JuneResearch2026ab Evidence UBS YES

Aritzia Inc Equities

AmericasUBS Evidence Lab inside: 1Q Preview: We See

Limited Volatility Over the Event Retailers, Apparel

12-month rating Buy *

12m price target C$204.00We expect a solid 1Q report, but so does the market:

Prior : C$189.00

Our analyses indicate Aritzia maintained robust momentum in 1Q27 and this strength

has continued 2QTD. We thus forecast a 7c 1Q EPS beat and expect ATZ to provide solid Price (25 Jun 2026) C$159.27

2Q guidance. We also anticipate ATZ to raise its FY27 sales growth outlook by 100-200 RIC: ATZ.TO BBG: ATZ CN

bps while maintaining its adj. EBITDA guidance. That said, we believe the market already

envisions a similar outcome and therefore doubt ATZ's 1Q report drives big changes on Trading data and key metrics

sentiment or its P/E. The options market is pricing in a +/-10.1% move over earnings vs. 52-wk range C$173.20-69.21

an 8.2% historical avg. move. We anticipate less volatility than +/-8.2%. Market cap. C$19.0b/US$13.4b

Shares o/s 119m (COM)

Sentiment around ATZ leans bullish, in our view: Free float 100%

ATZ's stock is up 34% and has outperformed the S&P 500 by 2,700 bps YTD. Plus, its Avg. daily volume ('000) 642

FY2 P/E of ~28x indicates the stock is trading at an 80% premium vs. Softlines peers. Avg. daily value (m) C$91.5

Also, UBS Quant team's data revealed ATZ is long-crowded with a 9.5 crowding score vs. Common s/h equity (02/27E) C$1.87b

Softlines peers' 4.1 avg. These stats indicate sentiment leans bullish. While still positive, P/BV (02/27E) 9.3x

some investors have expressed concerns about a potential slowdown in Canada Net debt to EBITDA (02/27E) NM